|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Doxorubiein and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial 显示文摘 | Jassem J Pienkowski T Pluzanska A | 2009 | Onkologie2009，32，89： | 1 |
| 2 | Phase Ⅲ study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial显示文摘 | Gatzemeier U Pluzanska A Szczesna A | 2007 | J Clin Oncol2007，25，12： | 1 |
| 3 | A multicenter,randomized, Phase Ⅲ study of docetaxel plus best supportive care versus best supportive care in chemotherapy- naive patients with metastatic or nonresectable localized non - small cell lung cancer ( NSCLC ) 显示文摘 | Roszkowski K Pluzanska A Krzakowski M | 2000 | Lung Cancer2000，27，： | 1 |
| 4 | Phase Ⅲ study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial 显示文摘 | Gatzemeier U Pluzanska A Szczesma A | 2007 | J Clin Oncol2007，25，12： | 1 |
| 5 | Phse Ⅲ study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer:The Tarceva Lung Cancer Investigation Trial显示文摘 | Gatzemeier U Pluzanska A Szczesna A | 2007 | J Clin Oncol2007，25，： | 1 |
| 6 | Doxorubicin and paclitaxel versus fiuorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase Ⅲmulticenter trial 显示文摘 | Jassem J Pienkowski T Pluzanska A | 2001 | J Clin Oncol2001，19，6： | 1 |
| 7 | Phase multicenter trial comparing Toxol/doxorubicin(AT) vs 5-fulorouracil/doxorubicin and cyclophosphamide(FAC) as a first line treatment for patient with metastatic breast cancer显示文摘 | Pienkowski T Jelic S | 1999 | Breast cancer Res Treat1999，57，： | 1 |
| 8 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase Ⅲ trial显示文摘 | Escudier B Pluzanska A Koralewski P | 2007 | The Lancet2007，370，9605： | 1 |
| 9 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma:a randomised,double-blind phase Ⅲ tria显示文摘 | ESCUDIER B PLUZANSKA A KORALEWSKI P | 2007 | Lancer2007，370，9605： | 1 |
| 10 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double- blind phase III trial 显示文摘 | Escudier B Pluzanska A Koralewski P | 2007 | Lancet2007，370，9605： | 1 |
| 11 | Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva lung cancer investigation trial 显示文摘 | Gatzemeier U Pluzanska A Szczesna A | 2007 | J Clin Oncol2007，5，12： | 1 |
| 12 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma:a randomised,double-blind phaseⅢtrial显示文摘 | Escudier B Pluzanska A Koralewski P | 2007 | Lancet2007，370，9605： | 1 |
| 13 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase Ⅱ trial 显示文摘 | Escudier B Pluzanska A Koralewsk P | 2007 | Lancet2007，370，9605： | 1 |
| 14 | A multicenter,randomized,phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy na?ve patients with metastatic or non-resectable localized Non-small Cell Lung Cancer(NSCLC)显示文摘 | Roszkowski K Pluzanska A Krzakowski M | 2000 | Lung Cancer2000，27，： | 1 |
| 15 | A multicenter,randomized, phase Ⅲ study of docetaxel plus best supportive care versus best supportive care in chemotherapy naive patients with metastatatic non-resectable localized non-small cell lung cancer显示文摘 | Roszkowki K Pluzanska A Krzakowski M er al | 2000 | Lung Cancer2000，27，3： | 1 |
| 16 | Bevaeizumab plus interferon alfa-2a for treatment of metastatic renal cell eareinoma~ a randomized, double-blind phase Ⅲ trial 显示文摘 | Eseudier B Pluzanska A Koralewski P | 2007 | Lancet2007，370，9605： | 1 |
| 17 | Phase III study of erlotinib in combination with eisplatin and gemcit- abine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial 显示文摘 | Gatzemeier U Pluzanska A Szczesna A | 2007 | J Clin Oncol2007，25，： | 1 |
| 18 | Phase Ⅲ study of erlotinib in combination with cisplatin and gemcit abine in advanced non small cell lung cancer: the Tarceva Lung Cancer Investigation Trial显示文摘 | Gatzemeier U Pluzanska A Szczesna A | 2007 | J Clin Oncol2007，25，12： | 1 |
| 19 | Amulticenter,randomized,phaseⅢstudy of docetaxel plus best supportive careversus best supportive care in chemotherapy-naive patients withmetastatic or non-resectable localized non-small cell lung cancer显示文摘 | Roszkowski K Pluzanska A Krzakowski M | 2000 | Lung Cancer2000，27，3： | 1 |
| 20 | Results of a phase Ⅲ trial of erlotinib combined with cisplatin and gecitabine chemotherapy in advanced non-small cell lung cancer(NSCLC)显示文摘 | GATZEMEIER U PLUZANSKA A SZCZESNA A | 2007 | J Clin Oncol2007，25，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员